Finance

Lists
Why is MRK down 2,39%?
Dive Deeper
MRK:NYSE
Merck & Co Inc
141,98 US$
-2,39%
(-3,47) 1D
142,20 US$
+0,15% (+0,22)
After hours
Closed: 13 ოქტ, 16:03:10 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
145,85 US$
High
145,93 US$
Low
141,58 US$
Mkt. cap
350,29 მლრ.
Avg. vol.
9,42 მლნ.
Volume
0,00
Dividend
2,39%
Quarterly dividend
0,85 US$
Ex-dividend date
15 სექ. 2026
P/E ratio
113,40
52-wk high
156,92 US$
52-wk low
82,01 US$
EPS
1,25 US$
Beta
0,21
Shares outstanding
2,47 მლრდ.
No. of employees
74 ათ.
Open
145,85 US$
High
145,93 US$
Low
141,58 US$
Mkt. cap
350,29 მლრ.
Avg. vol.
9,42 მლნ.
Volume
0,00
Dividend
2,39%
Quarterly dividend
0,85 US$
Ex-dividend date
15 სექ. 2026
P/E ratio
113,40
52-wk high
156,92 US$
52-wk low
82,01 US$
EPS
1,25 US$
Beta
0,21
Shares outstanding
2,47 მლრდ.
No. of employees
74 ათ.
News stories
From web sources and news partners
News Corp
News Corp
·
10 საათის წინ
Can a Spinoff Fix Johnson & Johnson’s Medtech Problem?
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEOრობერ ემ დავის
Employees74 ათ.
Founded1 იან. 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Analyst ratings
Based on 21 analysts giving stock ratings to MRK in the past 3 months
Buy
Buy
15
Hold
6
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for MRK in the last 3 months.
Highest
Current 141,98 US$
180,00 US$ (+26,78%)
Average
160,24 US$ (+12,86%)
Lowest
105,00 US$ (-26,05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Evan Seigerman
BMO Capital
Buy
Maintained
170,00 US$
+19,7%
10/12/2026
Carter Gould
Cantor Fitzgerald
Hold
Maintained
145,00 US$
+2,1%
10/11/2026
Daina Graybosch
Leerink Partners
Buy
Maintained
161,00 US$
+13,4%
10/12/2026
Trung Huynh
RBC Capital
Hold
Reiterated
145,00 US$
+2,1%
10/12/2026
Geoff Meacham
Citi
Hold
Maintained
145,00 US$
+2,1%
10/13/2026
Emily Field
Barclays
Buy
Maintained
150,00 US$
+5,6%
10/12/2026
Michael Yee
UBS
Buy
Maintained
175,00 US$
+23,3%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
163,00 US$
+14,8%
10/09/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
177,00 US$
+24,7%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Maintained
165,00 US$
+16,2%
10/05/2026
Asad Haider
Goldman Sachs
Buy
Maintained
160,00 US$
+12,7%
09/30/2026
Louise Chen
Scotiabank
Buy
Maintained
180,00 US$
+26,8%
09/29/2026
Steve Scala
TD Cowen
Hold
Maintained
155,00 US$
+9,2%
09/22/2026
Nico Chen
DBS
Buy
Maintained
180,00 US$
+26,8%
09/11/2026
Rajesh Kumar
HSBC
Buy
Maintained
172,00 US$
+21,1%
09/10/2026
Vamil Divan
Guggenheim
Buy
Reiterated
170,00 US$
+19,7%
09/08/2026
Courtney Breen
Bernstein
Hold
Maintained
105,00 US$
-26%
09/07/2026
Mohit Bansal
Wells Fargo
Buy
Reiterated
170,00 US$
+19,7%
09/04/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
170,00 US$
+19,7%
08/24/2026
Alexandria Hammond
Wolfe Research
Buy
Maintained
180,00 US$
+26,8%
08/25/2026
Luisa Hector
Berenberg Bank
Hold
Maintained
127,00 US$
-10,6%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
138,00 US$
-2,8%
05/19/2026
Unknown Analyst
Argus Research
Buy
Reiterated
130,00 US$
-8,4%
05/08/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Maintained
179,00 US$
+26,1%
04/17/2026
James Shin
Deutsche Bank
Buy
Upgraded
150,00 US$
+5,6%
02/13/2026
Last report
4 აგვ. 2026
Fiscal period
Q2 2026
-0,13 US$ / -0,26 US$
+49,43%beat
Revenue / Est. (USD)
16,61 მლრდ. / 16,37 მლრდ.
+1,46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
17,28 მლრდ.
16,40 მლრდ.
16,29 მლრდ.
16,61 მლრდ.
Cost of goods sold
3,74 მლრდ.
4,30 მლრდ.
3,88 მლრდ.
4,13 მლრდ.
Cost of revenue
3,74 მლრდ.
4,30 მლრდ.
3,88 მლრდ.
4,13 მლრდ.
Research and development expenses
4,00 მლრდ.
4,00 მლრდ.
3,56 მლრდ.
9,74 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,48 მლრდ.
2,73 მლრდ.
2,57 მლრდ.
2,78 მლრდ.
Operating expense
6,48 მლრდ.
6,73 მლრდ.
6,12 მლრდ.
12,52 მლრდ.
Total operating expenses
10,23 მლრდ.
11,02 მლრდ.
10,00 მლრდ.
16,65 მლრდ.
Operating income
7,05 მლრდ.
5,38 მლრდ.
6,29 მლრდ.
-40,00 მლნ.
Other non operating income
-
41,00 მლნ.
42,00 მლნ.
59,00 მლნ.
EBT including unusual items
6,74 მლრდ.
3,42 მლრდ.
-3,53 მლრდ.
-683,00 მლნ.
EBT excluding unusual items
6,76 მლრდ.
4,98 მლრდ.
5,85 მლრდ.
-508,00 მლნ.
Income tax expense
958,00 მლნ.
458,00 მლნ.
709,00 მლნ.
654,00 მლნ.
Effective tax rate
14,20%
13,39%
-20,06%
-95,75%
Other operating expenses
-
-
-
-
Net income
5,78 მლრდ.
2,96 მლრდ.
-4,24 მლრდ.
-1,34 მლრდ.
Net profit margin
33,49%
18,07%
-26,03%
-8,04%
Earnings per share
2,58
2,04
-1,28
-0,13
Interest and investment income
96,00 მლნ.
69,00 მლნ.
35,00 მლნ.
35,00 მლნ.
Interest expense
-327,00 მლნ.
-411,00 მლნ.
-479,00 მლნ.
-525,00 მლნ.
Net interest expenses
-231,00 მლნ.
-342,00 მლნ.
-444,00 მლნ.
-490,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
8,15 მლრდ.
6,79 მლრდ.
7,69 მლრდ.
1,43 მლრდ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები